Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a new Locations section with North Carolina as a study site. Removed the North Carolina Locations entry and the HHS Vulnerability Disclosure link; updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:40:15.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page.
    Difference
    0.1%
    Check dated 2025-11-25T11:39:44.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Removed the government funding status notice about potential delays and NIH operations. This administrative change does not affect the study details, eligibility criteria, outcomes, or locations.
    Difference
    0.4%
    Check dated 2025-11-18T07:14:09.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The screenshots display the same study details with no changes to the intervention, outcomes, or eligibility criteria; any differences seem to be cosmetic or layout adjustments.
    Difference
    0.5%
    Check dated 2025-11-03T21:18:45.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and a v3.2.0 version appears, replacing the old v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:57:42.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:34.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.